Ask AI
Global BBM Think Tank Commentary

CE / CME

Promise, Pitfalls, and Pathways: Global Perspectives on Blood-Based Biomarkers for Alzheimer’s Care

Physician Assistants/Physician Associates: 0.25 AAPA Category 1 CME credit

European Learners: 0.25 EBAC® CE Credit

Physicians: maximum of 0.25 AMA PRA Category 1 Credit

Nurse Practitioners/Nurses: 0.25 Nursing contact hour

Released: June 03, 2026

Expiration: June 02, 2027

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

How many people with Alzheimer’s disease do you provide care for in a typical week?

2.

For those who practice in academic or community settings, please indicate your practice setting:

3.

In which clinical scenario would you most recommend blood-based biomarker (BBM) testing for Alzheimer’s disease (AD)?